Cargando…
DJ-1 Expression Might Serve as a Biologic Marker in Patients with Bladder Cancer
SIMPLE SUMMARY: Although serum DJ-1 has been evaluated in some types of cancer, it has not been analyzed in detail in bladder cancer (BC). Furthermore, DJ-1 expression patterns in BC and their clinicopathologic significance and relationship with prognosis are unclear. In the present study, we evalua...
Autores principales: | Hirano, Shuhei, Matsumoto, Kazumasa, Tanaka, Kei, Amano, Noriyuki, Koguchi, Dai, Ikeda, Masaomi, Shimizu, Yuriko, Tsuchiya, Benio, Nagashio, Ryo, Sato, Yuichi, Iwamura, Masatsugu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139869/ https://www.ncbi.nlm.nih.gov/pubmed/35626138 http://dx.doi.org/10.3390/cancers14102535 |
Ejemplares similares
-
Serum Epiplakin Might Be a Potential Serodiagnostic Biomarker for Bladder Cancer
por: Shimura, Soichiro, et al.
Publicado: (2021) -
Prognostic Impact of AHNAK2 Expression in Patients Treated with Radical Cystectomy
por: Koguchi, Dai, et al.
Publicado: (2021) -
Expression of Membranous CD155 Is Associated with Aggressive Phenotypes and a Poor Prognosis in Patients with Bladder Cancer
por: Mori, Kohei, et al.
Publicado: (2022) -
Expression of S100A16 Is Associated with Biological Aggressiveness and Poor Prognosis in Patients with Bladder Cancer Who Underwent Radical Cystectomy
por: Katsumata, Hiroki, et al.
Publicado: (2023) -
Gemcitabine–Paclitaxel Chemotherapy for Patients with Advanced Urothelial Cancer Refractory to Cisplatin-Based Chemotherapy: Predictive Role of PGK1 for Treatment Response to Cytotoxic Chemotherapy
por: Koguchi, Dai, et al.
Publicado: (2022)